领航医药生物科技拟发行1.45亿股配售股份 净筹5882.5万港元

Core Viewpoint - The company has announced a placement agreement with a placement agent to issue up to 145 million shares at a price of HKD 0.415 per share, representing a discount of approximately 9.78% from the closing price of HKD 0.46 on August 21, 2025 [1] Group 1 - The placement is aimed at attracting at least six independent third-party subscribers [1] - If fully subscribed, the 145 million shares will account for about 6.34% of the company's enlarged issued share capital [1] - The total expected proceeds from the placement are approximately HKD 60.175 million, with net proceeds estimated at around HKD 58.825 million after deducting related expenses [1]